| James Randall, MD | |
|
1221 N 26th St, Billings, MT 59101-0232 | |
| (406) 252-5681 | |
| (406) 252-5025 |
| Full Name | James Randall |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 1221 N 26th St, Billings, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275528432 | NPI | - | NPPES |
| 073957 | Medicaid | MT | |
| 807213000 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 5055 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James Randall, MD 1221 N 26th St, Billings, MT 59101-0232 Ph: (406) 252-5681 | James Randall, MD 1221 N 26th St, Billings, MT 59101-0232 Ph: (406) 252-5681 |
News Archive
The adverse effects of using prescription drugs side by side with natural health products (NHP) are being under-reported, so the potential risks may be underestimated by health-care professionals and the public, a study from the University of Alberta in Edmonton, Canada shows.
More than 80% of hospitalized patients suffer more severe pain than necessary. This is the conclusion of Christoph Maier (Bochum University Hospital, Bochum, Germany) and his coauthors in their interim report of the Pain-Free Hospital Project ("Schmerzfreies Krankenhaus"), which appears in the current issue of Deutsches -rzteblatt International. The project, which was initiated in 2003, has the goal of improving pain management in hospitals across Germany.
Two novel radiolabeled small molecules targeting prostate-specific membrane antigen (PSMA) have excellent potential for further development as diagnostic and therapeutic radiopharmaceuticals, according to research published this month in The Journal of Nuclear Medicine.
Delcath Systems, Inc., a development stage, oncology-focused, specialty pharmaceutical and medical device company, announced that its Phase III National Cancer Institute (NCI)-led multi-center clinical trial has successfully met the study's primary endpoint of extended hepatic progression-free survival (hPFS) in patients with melanoma metastases to the liver based on an independently corroborated intent-to-treat analysis.
A system that allows surgeons to perform laparoscopic gastric bypass surgery from a remote console, controlling up to three robotic arms and a binocular camera, was successfully tested in 10 patients, according to a study in the August issue of Archives of Surgery.
› Verified 7 days ago
Jerald A. Bell, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2501 | |
Deborah G. Keenum, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Daniel T. Weaver, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
James S. Good, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2825 8th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
James Peter Cornetet, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
James Thomas Priddy, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4033 Avenue B, Billings, MT 59106 Phone: 406-256-6000 Fax: 406-256-9006 |